Annual Working Capital
$3.54 M
-$3.37 M-48.74%
December 31, 2023
Summary
- As of February 7, 2025, PTIX annual working capital is $3.54 million, with the most recent change of -$3.37 million (-48.74%) on December 31, 2023.
- During the last 3 years, PTIX annual working capital has risen by +$3.32 million (+1482.46%).
- PTIX annual working capital is now -85.62% below its all-time high of $24.65 million, reached on December 31, 2008.
Performance
PTIX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$633.40 K
-$60.90 K-8.77%
September 30, 2024
Summary
- As of February 7, 2025, PTIX quarterly working capital is $633.40 thousand, with the most recent change of -$60.90 thousand (-8.77%) on September 30, 2024.
- Over the past year, PTIX quarterly working capital has dropped by -$60.90 thousand (-8.77%).
- PTIX quarterly working capital is now -97.89% below its all-time high of $30.05 million, reached on March 31, 2008.
Performance
PTIX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
PTIX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -48.7% | -8.8% |
| 3 y3 years | +1482.5% | -8.8% |
| 5 y5 years | +1776.0% | -8.8% |
PTIX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -65.5% | at low | -93.8% | at low |
| 5 y | 5-year | -65.5% | +1097.7% | -94.5% | +239.2% |
| alltime | all time | -85.6% | +120.6% | -97.9% | +106.5% |
Protagenic Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $633.40 K(-8.8%) |
| Jun 2024 | - | $694.30 K(-65.7%) |
| Mar 2024 | - | $2.02 M(-43.0%) |
| Dec 2023 | $3.54 M(-48.7%) | $3.54 M(-13.5%) |
| Sep 2023 | - | $4.10 M(-24.3%) |
| Jun 2023 | - | $5.41 M(-15.6%) |
| Mar 2023 | - | $6.41 M(-7.3%) |
| Dec 2022 | $6.92 M(-32.6%) | $6.92 M(-10.2%) |
| Sep 2022 | - | $7.70 M(-9.9%) |
| Jun 2022 | - | $8.55 M(-5.1%) |
| Mar 2022 | - | $9.01 M(-12.1%) |
| Dec 2021 | $10.26 M(+4480.5%) | $10.26 M(-6.1%) |
| Sep 2021 | - | $10.93 M(-4.6%) |
| Jun 2021 | - | $11.46 M(-2619.1%) |
| Mar 2021 | - | -$454.90 K(-303.1%) |
| Dec 2020 | $224.00 K(-163.0%) | $224.00 K(-22.7%) |
| Sep 2020 | - | $289.90 K(-25.3%) |
| Jun 2020 | - | $387.90 K(-1107.5%) |
| Mar 2020 | - | -$38.50 K(-89.2%) |
| Dec 2019 | -$355.30 K(+68.0%) | -$355.30 K(-2.4%) |
| Sep 2019 | - | -$364.10 K(-4.2%) |
| Jun 2019 | - | -$379.90 K(+4.8%) |
| Mar 2019 | - | -$362.40 K(+71.3%) |
| Dec 2018 | -$211.50 K(-117.4%) | -$211.50 K(-165.6%) |
| Sep 2018 | - | $322.30 K(-42.4%) |
| Jun 2018 | - | $559.10 K(-42.0%) |
| Mar 2018 | - | $964.00 K(-20.9%) |
| Dec 2017 | $1.22 M(-50.8%) | $1.22 M(-27.6%) |
| Sep 2017 | - | $1.68 M(-10.3%) |
| Jun 2017 | - | $1.88 M(-13.8%) |
| Mar 2017 | - | $2.18 M(-12.1%) |
| Dec 2016 | $2.48 M(-4443.7%) | $2.48 M(-15.7%) |
| Sep 2016 | - | $2.94 M(-7.8%) |
| Jun 2016 | - | $3.19 M(+5.6%) |
| Mar 2016 | - | $3.01 M(-447.7%) |
| Dec 2015 | - | -$867.00 K(+22.5%) |
| Sep 2015 | - | -$708.00 K(+1142.1%) |
| Jun 2015 | -$57.00 K(-154.8%) | -$57.00 K(-87.5%) |
| Mar 2015 | - | -$456.00 K(+38.6%) |
| Dec 2014 | - | -$329.00 K(+73.2%) |
| Sep 2014 | - | -$190.00 K(-282.7%) |
| Jun 2014 | $104.00 K(-100.6%) | $104.00 K(-101.1%) |
| Jun 2013 | -$17.23 M(-939.5%) | - |
| Sep 2011 | - | -$9.76 M(+46.7%) |
| Jun 2011 | - | -$6.65 M(+725.6%) |
| Mar 2011 | - | -$806.00 K(-139.3%) |
| Dec 2010 | $2.05 M | $2.05 M(-65.6%) |
| Sep 2010 | - | $5.96 M(-31.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2010 | - | $8.66 M(-31.3%) |
| Mar 2010 | - | $12.60 M(-17.9%) |
| Dec 2009 | $15.35 M(-37.7%) | $15.35 M(+6.3%) |
| Sep 2009 | - | $14.44 M(-29.3%) |
| Jun 2009 | - | $20.41 M(-6.3%) |
| Mar 2009 | - | $21.78 M(-11.6%) |
| Dec 2008 | $24.65 M(+75.6%) | $24.65 M(-6.2%) |
| Sep 2008 | - | $26.27 M(+2.8%) |
| Jun 2008 | - | $25.56 M(-14.9%) |
| Mar 2008 | - | $30.05 M(+114.0%) |
| Dec 2007 | $14.04 M(+1923.2%) | $14.04 M(-6.9%) |
| Sep 2007 | - | $15.08 M(-10.5%) |
| Jun 2007 | - | $16.86 M(-4.9%) |
| Mar 2007 | - | $17.74 M(<-9900.0%) |
| Dec 2006 | $694.00 K(-505.8%) | - |
| Oct 2006 | - | -$27.50 K(-83.9%) |
| Jul 2006 | - | -$171.00 K(+5.0%) |
| Jul 2006 | -$171.00 K(+81.0%) | - |
| Apr 2006 | - | -$162.80 K(+5.7%) |
| Jan 2006 | - | -$154.00 K(+8.5%) |
| Oct 2005 | - | -$141.90 K(-105.4%) |
| Jul 2005 | -$94.50 K(-101.4%) | - |
| Jul 2004 | $6.52 M(+91.9%) | - |
| Apr 2003 | - | $2.63 M(+13.3%) |
| Jan 2003 | - | $2.32 M(-22.9%) |
| Oct 2002 | - | $3.01 M(-11.5%) |
| Jul 2002 | $3.40 M(-16.3%) | $3.40 M(-13.4%) |
| Apr 2002 | - | $3.92 M(-4.7%) |
| Jan 2002 | - | $4.12 M(-0.1%) |
| Oct 2001 | - | $4.12 M(+1.4%) |
| Jul 2001 | $4.06 M(-21.1%) | $4.06 M(-16.3%) |
| Apr 2001 | - | $4.85 M(-13.9%) |
| Jan 2001 | - | $5.64 M(+2.2%) |
| Oct 2000 | - | $5.52 M(+7.1%) |
| Jul 2000 | $5.15 M(+9.7%) | $5.15 M(-3.3%) |
| Apr 2000 | - | $5.33 M(-3.2%) |
| Jan 2000 | - | $5.50 M(+0.1%) |
| Oct 1999 | - | $5.50 M(+17.1%) |
| Jul 1999 | $4.70 M(-13.6%) | $4.70 M(+2.1%) |
| Apr 1999 | - | $4.60 M(-17.9%) |
| Jan 1999 | - | $5.60 M(-3.4%) |
| Oct 1998 | - | $5.80 M(+6.6%) |
| Jul 1998 | $5.44 M(-16.3%) | $5.44 M(-10.8%) |
| Apr 1998 | - | $6.10 M(+7.0%) |
| Jan 1998 | - | $5.70 M(-17.4%) |
| Oct 1997 | - | $6.90 M(+6.2%) |
| Jul 1997 | $6.50 M | $6.50 M(-8.5%) |
| Apr 1997 | - | $7.10 M(-2.7%) |
| Jan 1997 | - | $7.30 M |
FAQ
- What is Protagenic Therapeutics annual working capital?
- What is the all time high annual working capital for Protagenic Therapeutics?
- What is Protagenic Therapeutics annual working capital year-on-year change?
- What is Protagenic Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Protagenic Therapeutics?
- What is Protagenic Therapeutics quarterly working capital year-on-year change?
What is Protagenic Therapeutics annual working capital?
The current annual working capital of PTIX is $3.54 M
What is the all time high annual working capital for Protagenic Therapeutics?
Protagenic Therapeutics all-time high annual working capital is $24.65 M
What is Protagenic Therapeutics annual working capital year-on-year change?
Over the past year, PTIX annual working capital has changed by -$3.37 M (-48.74%)
What is Protagenic Therapeutics quarterly working capital?
The current quarterly working capital of PTIX is $633.40 K
What is the all time high quarterly working capital for Protagenic Therapeutics?
Protagenic Therapeutics all-time high quarterly working capital is $30.05 M
What is Protagenic Therapeutics quarterly working capital year-on-year change?
Over the past year, PTIX quarterly working capital has changed by -$60.90 K (-8.77%)